XML 37 R35.htm IDEA: XBRL DOCUMENT v3.2.0.727
Notes and Lines of Credit Payable - Additional Information (Detail) - USD ($)
1 Months Ended 3 Months Ended
Mar. 28, 2014
Jun. 30, 2015
Jun. 30, 2014
Aug. 18, 2015
Mar. 31, 2015
Dec. 20, 2013
Oct. 15, 2013
Senior Secured Note [Line Items]              
Debt, maturity date   Mar. 28, 2019          
Debt Instrument, Unamortized Discount   $ 995,363     $ 1,060,401    
Amortization Of Debt Discount Premium   115,609 $ 79,381        
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 2.31%            
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate 71.40%            
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price $ 4.50            
Expected term 7 years            
Subsequent Event [Member]              
Senior Secured Note [Line Items]              
Debt Instrument, Face Amount       $ 250,000      
Debt Instrument, Unused Borrowing Capacity, Amount       $ 213,276      
Los Angeles Lung Center [Member]              
Senior Secured Note [Line Items]              
Line of credit facility amount outstanding   230,000          
Bay Area Hospitalist Associates [Member]              
Senior Secured Note [Line Items]              
Line of credit facility amount outstanding   150,000          
2014 NNA Financing              
Senior Secured Note [Line Items]              
Amortization Of Debt Discount Premium   20,930          
Related Party Costs   235,119          
Deferred Finance Costs Net   150,101          
Proceeds From Issuance Of Debt Instruments On Fair Value   $ 9,000,000          
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate   2.31%          
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate   71.40%          
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price   $ 4.50          
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate   50.00%          
Stock Issued During Period Value For Financing   $ 899,739          
Discount On Shares Issuance   1,100,261          
Discount On Term Loan   1,254,363          
Fair Value Of Warrant Liabilities   $ 2,354,624          
Expected term   7 years          
Amortization Of Debt Discount   $ 51,072          
Amortization Of Debt Discount Premium Related To Equity   7,998          
Term Loan Value Under Agreement   $ 5,745,637          
NNA              
Senior Secured Note [Line Items]              
Term Loan accrued interest   8.00%          
Investment Agreement              
Senior Secured Note [Line Items]              
Warrants To Purchase Common Stock   200,000          
Class of Warrant or Right, Exercise Price of Warrants or Rights   $ 20.00          
Pledge and Security Agreement              
Senior Secured Note [Line Items]              
Securities Owned and Pledged as Collateral, Description   Pledged interests as of the date of the Pledge and Security Agreement include 100% of AMM, PCCM, VMM common stock and 72.77% of ApolloMed ACO common stock.          
Revolving Credit Facility              
Senior Secured Note [Line Items]              
Revolving line of credit carrying amount   $ 100,000         $ 2,000,000
Line of credit facility amount outstanding   $ 94,764          
Line of credit facility, interest rate description   prime rate (as defined) plus 4.50% (7.75% per annum at June 30, 2015 and at March 31, 2015)          
Line of credit facility, frequency of payment and payment terms   interest only is payable monthly, and the line of credit matures June 5, 2016          
Proceeds from Lines of Credit   $ 1,000,000          
Revolving Credit Facility | Maximum              
Senior Secured Note [Line Items]              
Line of credit facility, maximum borrowing capacity           $ 4,000,000  
Revolving Credit Facility | Minimum              
Senior Secured Note [Line Items]              
Line of credit facility, maximum borrowing capacity           $ 2,000,000  
Convertible Notes Payable              
Senior Secured Note [Line Items]              
Debt, interest rate 8.00%            
Debt, maturity date Mar. 28, 2019            
Debt Instrument, Fee Amount $ 2,000,000            
Debt Instrument, Convertible, Terms of Conversion Feature The Company may redeem amounts outstanding under the Convertible Note on 60 days prior notice to NNA.            
Debt Instrument, Convertible, Conversion Price $ 10.00            
NNA Warrants | Investment Agreement              
Senior Secured Note [Line Items]              
Warrants To Purchase Common Stock   300,000          
Class of Warrant or Right, Exercise Price of Warrants or Rights   $ 10.00          
Senior secured note | SpaGus              
Senior Secured Note [Line Items]              
Senior notes   $ 500,000          
Term Loan              
Senior Secured Note [Line Items]              
Line of credit facility amount outstanding $ 7,000,000            
Repayment of first year term loan   87,500          
Repayment of second year term loan   122,500          
Repayment of third year term loan   122,500          
Repayment of fourth year term loan   175,000          
Repayment of fifth year term loan   210,000          
Debt Instrument, Unamortized Discount   1,305,435          
Debt Instrument, Fee Amount   $ 80,000          
Warrants To Purchase Common Stock   30,000          
Revolving Loan [Member]              
Senior Secured Note [Line Items]              
Line of credit facility amount outstanding $ 1,000,000            
Line of credit facility, interest rate description   three month LIBOR plus 6.0%          
Term Loan And Revolving Loan [Member]              
Senior Secured Note [Line Items]              
Debt, maturity date   Mar. 28, 2019          
Line of Credit Facility, Expiration Date   Mar. 28, 2019